Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

PDL BioPharma Inc. (PDLI)

3.68   0.09 (2.51%) 03-25 13:59
Open: 3.6 Pre. Close: 3.59
High: 3.71 Low: 3.6
Volume: 541,193 Market Cap: 537M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.793 - 3.812 3.812 - 3.824
Low: 3.546 - 3.57 3.57 - 3.586
Close: 3.555 - 3.592 3.592 - 3.615

Technical analysis

as of: 2019-03-25 1:32:10 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 4.46     One year: 5.21
Support: Support1: 3.50    Support2: 3.31
Resistance: Resistance1: 3.82    Resistance2: 4.46
Pivot: 3.60
Moving Average: MA(5): 3.69     MA(20): 3.63
MA(100): 3.13     MA(250): 2.83
MACD: MACD(12,26): 0.08     Signal(9): 0.08
Stochastic oscillator: %K(14,3): 64.41     %D(3): 68.02
RSI: RSI(14): 57.90
52-week: High: 3.82  Low: 2.25  Change(%): 25.3
Average Vol(K): 3-Month: 162310  10-Days: 171324

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
PDLI has closed below upper band by 26.2%. Bollinger Bands are 23.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 15 Mar 2019 17:12:23 Z
PDL BioPharma (PDLI) Q4 Earnings Top Mark, Revenues Fall Y/Y

Fri, 15 Mar 2019 10:08:43 Z
PDL BioPharma Inc. (PDLI) Q4 2018 Earnings Conference Call Transcript

Mon, 25 Feb 2019 22:07:47 Z
4 Penny Stocks to Own for 2019

Sun, 17 Feb 2019 23:07:13 Z
Validea's Top Five Healthcare Stocks Based On Joseph Piotroski - 2/17/2019

Sun, 16 Dec 2018 23:06:33 Z
Validea's Top Five Healthcare Stocks Based On Joseph Piotroski - 12/16/2018

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 128.11
Shares Float (M) 121.53
% Held by Insiders 4.50
% Held by Institutions 130.00
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS 0.350
EPS Est. Current Year 0.610
EPS Est. Next Year 0.410
EPS Est. Next Quarter 0.130
Forward EPS 0.250
Book Value (p.s.) 0.670
PEG Ratio 1.53
Profit Margin -35.17
Operating Margin -17.45
Return on Assets (ttm) -6.2
Return on Equity (ttm) -8.7
Qtrly Rev. Growth -30.3
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth -27.10
Operating Cash Flow (M) -13.43
Levered Free Cash Flow (M) 37.18

Stock Valuations

P/E 10.53
P/E Growth Ratio 0.03
P/BV 5.50
P/S 707810880.00
P/CF -35.15

Dividends & Splits

Dividend Yield
Dividend Pay Date 2016-06-13
Ex-Dividend Date 2016-06-02
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.